Work

Phase 2 Study of Abemaciclib plus Pembrolizumab in KRAS Mutation, PD-L1+, Stage IV Non-Small Cell or Squamous Cell Lung Cancer

Year: 2017

Type: article

Authors: Julien Mazières, Sara M. Tolaney, Luis Paz‐Ares, Jean-Louis Pujol, Tuncay Göksel, Chia‐Chi Lin, Anwar Hossain, William J. John, Peter Kabos

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3027577589

FWCI:

Cites:

Cited by:

Related to: 10